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Introduction: The effects of different mechanical ventilation (MV) modes on mortality outcome in infants with
respiratory distress syndrome (RDS) are not well known.
Methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library,
EMBASE, MEDLINE, CINAHL, and Web of Science for studies published through April 2014 that assessed mortality
in infants with RDS given different MV modes. We assessed studies for eligibility, extracted data, and subsequently
pooled the data. A Bayesian fixed-effects model was used to combine direct comparisons with indirect evidence.
We also performed sensitivity analyses and rankings of the competing treatment modes.
Results: In total, 20 randomized controlled trials were included for the network meta-analysis, which consisted of
2,832 patients who received one of 16 ventilation modes. Compared with synchronized intermittent mandatory
ventilation (SIMV) + pressure support ventilation (PSV), time-cycled pressure-limited ventilation (TCPL) (hazard ratio
(HR) 0.290; 95% confidence interval (CI) 0.071 to 0.972), high-frequency oscillatory ventilation (HFOV) (HR 0.294; 95%
CI 0.080 to 0.852), SIMV + volume-guarantee (VG) (HR 0.122; 95% CI 0.014 to 0.858), and volume-controlled (V-C)
(HR 0.139; 95% CI 0.024 to 0.677) ventilation modes are associated with lower mortality. The combined results of
available ventilation modes were not significantly different in regard to the incidences of patent ductus arteriosus
and intraventricular hemorrhage.
Conclusion: Compared with the SIMV + PSV ventilation mode, the TCPL, HFOV, SIMV + VG, and V-C ventilation
modes are associated with lower mortality.Introduction
Respiratory distress syndrome (RDS) is a common clinical
disease that results from the deficiency of alveolar surfac-
tant along with the structural immaturity of the lungs in
preterm infants [1]. EuroNeoNet figures in 2010 indicated
RDS rates of 92% at 24 to 25 weeks, 88% at 26 to 27 weeks,
76% at 28 to 29 weeks, and 57% at 30 to 31 weeks of
gestation [2]. RDS remains the primary cause of infant
mortality [3].* Correspondence: changsongwang@aliyun.com; enyouli@aliyun.com
†Equal contributors
1Department of Anesthesiology, First Affiliated Hospital of Harbin Medical
University, No 23 Youzheng Str, Nangang District, Harbin, Heilongjiang
150001, China
Full list of author information is available at the end of the article
© 2015 Wang et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.The European Consensus Guidelines [1] for 2013
recommend that non-invasive respiratory support be
used at birth for all infants at risk for RDS, thereby
avoiding a greater chance of mechanical ventilation
(MV) [4]. However, non-invasive ventilation cannot
always provide effective oxygenation and stable lung
mechanics [5]. Therefore, MV remains an essential and
life-saving technique to care for preterm infants with RDS
for whom non-invasive ventilation fails [1].
Research has sought to develop ventilation that avoids
the development of lung injury and consequent broncho-
pulmonary dysplasia (BPD) as well as decreases the
mortality of preterm infants. However, the conclusions
associated with the efficacy and safety of these ventilation
techniques remain controversial [6,7], highlighting the
potential significance of the optimal ventilation mode forThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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attempted to identify the optimal ventilation mode for in-
fants with RDS via meta-analyses [8]. However, traditional
meta-analyses can compare only two treatments (or clas-
ses) that have been compared in head-to-head trials [9].
The MV of preterm infants with RDS contains many
modes, including assist/control (A/C) ventilation [10],
high-frequency oscillatory ventilation (HFOV) [7], volume
controlled (V-C) ventilation [11], and volume-guaranteed
(VG) ventilation [12]. Therefore, the ability to draw defini-
tive conclusions from the results of traditional meta-
analyses is limited. A network meta-analysis enables the
evaluation of the comparative effectiveness of multiple
interventions even though certain pairs might not be dir-
ectly compared. The idea that underlies network meta-
analysis methodology for a given comparison between two
treatments A and B is that direct evidence (which origi-
nates from studies that compare A with B) and indirect
evidence (which originates from the combination of stud-
ies through an intermediate comparator, for example, A
versus C and B versus C studies) can be synthesized into a
single effect size. Furthermore, this analysis has the poten-
tial to reduce the uncertainty in treatment effect estimates
[13]. However, certain methodological aspects are poorly
understood, and there are challenges in the application
and interpretation of data synthesis. This method is not
perfect and poses various challenges; for example, both
conceptual and statistical heterogeneity and incoherence
between included studies should be carefully assessed.
Furthermore, estimates of treatment effects should be
interpreted with attention to their uncertainty; though ap-
pealing, plain treatment rankings or probabilities derived
from network meta-analyses can be misleading [14]. In
this study, we attempted to provide suggestions for the
treatment of infants with RDS by taking advantage of a
network meta-analysis.
Methods
We conducted our systematic review in accordance with
the methods recommended by the preferred reporting
items for systematic reviews and meta-analyses (PRISMA)
guidelines [15].
Literature search
The trials were identified via electronic and manual
searches. We searched the Cochrane Central Register of
Controlled Trials (CENTRAL) in the Cochrane Library,
EMBASE, MEDLINE, CINAHL, and Web of Science by
using a combination of Medical Subject Headings
(MeSH) and text words (Additional file 1). We did not
restrict our search by language or year of publication.
The last search update was performed in April 2014. We
reviewed the reference lists of the published meta-
analyses. In addition, we manually searched the IndexMedicus for randomized controlled trials (RCTs), meta-
analyses, and systematic reviews for studies that the ini-
tial electronic search missed.
Literature inclusion and exclusion
Two groups independently assessed whether the litera-
ture reports should be included in the study analyses. To
resolve discrepancies between the decisions of these two
groups, the groups met, discussed, and jointly decided
whether a disputed report should be included. We first
used EndNote X6 to identify duplicate publications. We
subsequently removed reviews, retrospective studies, ob-
servational studies, case reports, experimental studies of
adults, animal studies, research that addressed physio-
logical mechanisms only, irrelevant studies (such as
studies of MV in patients who did not suffer from neo-
natal RDS, studies of pulmonary surfactant treatments,
and therapeutic approaches other than MV for infants
with RDS), duplicate reports, duplicate experiments
(such as assessments of other studies and reports that
described secondary or post hoc analyses of previously
published experimental data), and research that ad-
dressed non-invasive MV. After the full texts of the
remaining reports were obtained and carefully read,
non-randomized trials and experiments that used a
crossover design were excluded. Finally, RCTs of MV for
infants with RDS were included in the current analyses.
All studies included were of high quality and had a low
risk of bias; therefore, no publications were excluded on
the basis of research quality assessments.
Outcome measures and data extraction
The information extracted from the analyzed literature
included study-specific data (such as experimental de-
sign, inclusion criteria, and the time and location of the
experiments), information in regard to the selected in-
fants (such as gestational age and birth weight), the
specific processes used to conduct the experimental re-
search, the MV modes, and the clinical and safety out-
comes in regard to the infants with RDS. The primary
outcome of the current study was the mortality of the
infants with RDS; if an included investigation provided
multiple mortality rates, then the mortality rate associ-
ated with the longest follow-up period was analyzed.
The secondary outcomes of the current study included
pneumothorax, BPD, intraventricular hemorrhage (IVH)
(grade of at least III), patent ductus arteriosus (PDA),
length of intensive care unit (ICU) stay, and length of
hospital stay. IVH grading was performed by using the
scale of Papile et al. [16]. Two groups extracted data
from the included studies; these data sets were subse-
quently compared and verified. When necessary, data
extractions were sent to the original authors or reporters
for data supplementation and correction. We also
Wang et al. Critical Care  (2015) 19:108 Page 3 of 11contacted the authors of certain publications for their
assistance with missing or questionable data.
Statistical analyses
Direct and indirect evidence from all relevant studies
was integrated by using a network meta-analysis, and es-
timates with maximum power were provided [17]. A
network meta-analysis was performed by using the
GeMTC package in R (i386 3.0.2) [18]. Different time-
spans were used to calculate mortality across the in-
cluded studies; therefore, to achieve the maximum
accuracy and effectiveness [19], the current investigation
used hazard ratio (HR) values and 95% confidence inter-
vals (CIs) as approximations to measure mortality in in-
fants with RDS who received MV [20]. The statistical
analysis is based on Poisson likelihoods with a log link
function. Odds ratios (ORs) and 95% CIs were used to
measure the incidences of pneumothorax, IVH (grade of
at least III), and BPD in infants with RDS. The statistical
analysis was based on binomial likelihoods with a logit
link function. Mean differences (MDs) and CIs were
used to analyze the continuous variables of MV duration
and length of ICU stay. CIs were calculated by using a
Bayesian fixed-effects model that simulated the methods
of traditional probability theory. Cases in which the CIs
did not include 1.0 were considered significant. We per-
formed Bayesian analyses by using a Markov chain
Monte Carlo simulation to calculate the HRs, ORs, MDs,
and CIs [17].
Model selection was based on the guidelines of Dias
et al. [21] for the evaluation of linear models. Dbar indi-
cates the posterior mean of the residual deviance. pD indi-
cates the effective number of parameters (leverage). DIC
indicates the ‘deviance information criterion’. A smaller
Dbar value indicates a better model fit. However, the
model with the lowest DIC is generally chosen to aid in-
terpretation because it accounts for model complexity. A
lower DIC value indicates a better model fit. Differences
of less than 3 to 5 between the models were not con-
sidered significant [22]. A fixed-effect model (Additional
file 2) with HRs was chosen for the combined effect size
for mortality. A fixed-effect model (Additional files 3
and 4) with ORs was chosen as the combined effect sizes
for the incidences of PDA and IVH (grade of at least
III). The simulation generated 150,000 iterations, and
convergence was assessed by using the Brooks-Gelman-
Rubin diagnostic [23]. We used the ‘back-calculation’
[24] technique to evaluate the findings of the network
meta-analysis that originated from the direct versus in-
direct evidence for consistency. Within this analysis,
three types of models were estimated: unrelated study
effects, unrelated mean effects, and consistency.
The output of the summary function was plotted for
visual inspection. Forest plots and the I2 statistic wereused to investigate the possibilities of statistical hetero-
geneity and inconsistency between the direct and indir-
ect effect estimates by using the Higgins-Thompson
method (low heterogeneity = 25%, moderate heterogen-
eity = 50%, and high heterogeneity = 75%) [25]. We also
ranked the different interventions in terms of their likeli-
hood to obtain the best result for each outcome [26].
Each ventilation mode in the Markov chain Monte Carlo
cycle was classified on the basis of an estimated effect
size. These probabilities summed to 1 for each treatment
and each rank. X% denotes that the mode achieved x%
effectiveness; thus, larger percentages denote more ef-
fective interventions. However, these percentages indi-
cate possibilities only and are not deterministic [26].
Sensitivity analyses
For the sensitivity analyses, we eliminated studies by
Salvo et al. [27] and Castoldi et al. [28] from consider-
ation because these studies included participants with
gestational ages of 25 to 26 weeks; therefore, the exam-
ined populations were significantly different from the
participants of the other studies.
Results
We identified 7,299 studies for review on the basis of
their titles and abstracts (Figure 1). After an initial
screening, we retrieved the full text of 81 potentially eli-
gible articles for a detailed assessment. Finally, we ex-
cluded 61 irrelevant articles (Additional file 5), and 20
RCTs were included for network meta-analysis (Table 1),
which included 2,832 patients who received one of 16




All included studies reported information in regard to
mortality and therefore were included in the network
meta-analysis. One of these trials was a three-arm ex-
periment, and the remaining trials were two-arm experi-
ments. Compared with the synchronized intermittent
mandatory ventilation (SIMV) + pressure support venti-
lation (PSV) mode, the time-cycled pressure-limited ven-
tilation (TCPL), HFOV, SIMV + VG, and V-C modes
were associated with a reduction in mortality in the in-
fants with RDS. Specifically, the HRs (and 95% CIs) for
the TCPL, HFOV, SIMV + VG, and V-C modes were
0.290 (0.071 to 0.972), 0.294 (0.080 to 0.852), 0.122
(0.014 to 0.858), and 0.139 (0.024 to 0.677), respectively
(Figure 3). Compared with the high-frequency jet venti-
lation (HFJV) and patient-triggered ventilation (PTV)
modes, the V-C mode was associated with a reduction
in mortality in the infants with RDS, with HRs (95%
CIs) of 0.267 (0.073 to 0.897) and 0.269 (0.070 to 0.951)
Figure 1 Flow diagram of the literature search.
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and 5).
Additional file 6 summarizes the rankings of the com-
peting treatment modes with regard to mortality. The
SIMV + VG mode was associated with the greatest po-
tential to reduce mortality; the probability that this ven-
tilation approach was most effective was 29.7% most
likely; the V-C mode was the second-ranked ventilationapproach, with a probability of 22.8% most likely. The
A/C mode was most likely the worst approach with re-
spect to mortality, and the SIMV + PSV approach was
most likely to be ranked second or third from the bottom.
Comparisons of the mortality results from traditional
pairwise meta-analyses and the network meta-analysis
did not suggest statistical inconsistencies between the
direct and indirect evidence; moreover, none of the













































6 RDS Yes No No No No 1/1 No
Duman
et al. [10]
A/C + VG vs.
A/C













5 RDS Yes No 0/3 No 1/6 No 4/6
Guven
et al. [12]
SIMV + VG vs.
SIMV













7 RDS Yes 21 ± 12/
36 ± 23
No 53 ± 21/77 ± 33 No 3/6 No
Castoldi
et al. [28]
A/C + VG + RM
vs A/C + VG
20 747 ± 233/
737 ± 219
25 ± 2/25 ± 2 6 RDS Yes No No No 0/2 No 6/4
Carlo
et al. [29]
TCPL vs. HFJV 40 1,470 ± 350/
1408 ± 240
30 ± 2/30 ± 2 5 RDS Yes No 6/3 No 4/3 No No
HiFO Study
Group [30]
HFOV vs. TCPL 176 1,732 ± 979/
1,744 ± 853
31 ± 4/31 ± 4 7 RDS Yes No No No No No 24/28
Pardou
et al. [31]




5 RDS Yes No 5/3 No No 1/2 No
Wiswell
et al. [32]






















7 RDS Yes No 20/21 No No 11/13 No




6 RDS Yes No 62/47 No No No No
Lista
et al. [36]
PSV + VG vs.
PSV
































6 RDS Yes 66.2 ± 19.9/
62.8 ± 24.2





V-C vs. TCPL 109 985/976b 27.1/27.2b 7 RDS Yes No 2/4 No No 5/5 17/15
Liu
et al. [40]
SIPPV + VG vs.
HFOV vs. IMV















7 RDS Yes No 10/21 27.0 ± 20.2/
31.6 ± 21.7
13/28 No No
‘Yes’ represents the existence of a result, and ‘No’ refers to no result. aMedian (95% confidence limits), bmean, cmedian (interquartile range). A/C, assist-control ventilation; A/C + VG, assist-control plus volume-guarantee
ventilation; A/C + VG + RM, assist-control plus volume-guarantee ventilation with recruitment maneuver; BDP, bronchopulmonary dysplasia; HFFIV, high-frequency flow interrupted ventilation; HFJV, high-frequency jet
ventilation; HFOV, high-frequency oscillatory ventilation; ICU, intensive care unit; IMV, intermittent mandatory ventilation; IVH, intraventricular hemorrhage; PDA, patent ductus arteriosus; PSV, pressure support ventilation;
PSV + VG, pressure support ventilation with volume-guarantee ventilation; PTV, patient-triggered ventilation; RDS, respiratory distress syndrome; SIMV, synchronized intermittent mechanical ventilation; SIMV + PSV, synchronized
intermittent mechanical ventilation with pressure support ventilation; SIMV + VG, synchronized intermittent mechanical ventilation with volume-guarantee ventilation; SIPPV + VG, synchronized intermittent positive pressure










Figure 2 Network of the comparisons for the Bayesian network
meta-analysis. The size of the nodes is proportional to the number
of patients (in parentheses) randomly assigned to receive the
treatment. The width of the lines is proportional to the number of
trials (next to the line) that compare the connected treatments. A/C,
assist-control ventilation; A/C + VG, assist-control plus volume-
guarantee ventilation; A/C + VG + RM, assist-control plus volume-
guarantee ventilation with recruitment maneuver; CMV, continuous
mandatory ventilation; HFFIV, high-frequency flow interrupted
ventilation; HFJV, high-frequency jet ventilation; HFOV, high-frequency
oscillatory ventilation; IMV, intermittent mandatory ventilation; PSV,
pressure support ventilation; PSV + VG, pressure support ventilation
with volume-guarantee ventilation; PTV, patient-triggered ventilation;
SIMV, synchronized intermittent mechanical ventilation; SIMV + PSV,
synchronized intermittent mechanical ventilation with pressure support
ventilation; SIMV + VG, synchronized intermittent mechanical
ventilation with volume-guarantee ventilation; SIPPV + VG, synchronized
intermittent positive pressure ventilation plus volume-guarantee
ventilation; V-C, volume-controlled (through adjusting the delivered tidal
volume).
Table 2 The 16 ventilation modes for infants with
respiratory distress syndrome
HFFIV High-frequency flow interrupted ventilation
TCPL Time-cycled pressure-limited ventilation
HFOV High-frequency oscillatory ventilation
A/C + VG Assist-control plus volume-guarantee ventilation
A/C Assist-control ventilation
SIMV + VG Synchronized intermittent mechanical ventilation
with volume-guarantee ventilation
SIMV Synchronized intermittent mechanical ventilation
A/C + VG + RM Assist-control plus volume-guarantee ventilation with
recruitment maneuver
PSV + VG Pressure support ventilation with volume-guarantee
ventilation
PSV Pressure support ventilation
V-C Volume-controlled (through adjusting the delivered
tidal volume)
PTV Patient-triggered ventilation
IMV Intermittent mandatory ventilation
SIPPV + VG Synchronized intermittent positive pressure ventilation
plus volume-guarantee ventilation
HFJV High-frequency jet ventilation
SIMV + PSV Synchronized intermittent mechanical ventilation with
pressure support ventilation
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file 7).
The sensitivity analysis that excluded the articles by
Salvo et al. [27] and Castoldi et al. [28] from the analysis
did not change the reported results. Therefore, a differ-
ent gestational age did not result in statistical heterogen-
eity in our network meta-analysis, and our final results
included the articles by Salvo et al. [27] and Castoldi et al.
[28], as previously described.
Secondary outcomes
Patent ductus arteriosus
We identified eight trials with 584 participants that re-
ported the incidences of PDA. However, we were able to
include only 519 participants randomly assigned across
five treatment modes from six trials [11,30,33,37-39] in
our network meta-analysis because the incidence of
PDA in two studies [10,28] could not be incorporated
into the network analysis. The combined results of thedirect and indirect comparisons demonstrated that these
five ventilation modes exhibited no differences with re-
spect to the incidences of PDA (Additional file 8). Fur-
thermore, no statistical inconsistencies were identified
between the direct and indirect comparisons, and none
of the comparisons exhibited statistical heterogeneity
(Additional file 9).
Incidences of intraventricular hemorrhage (grade of at
least III)
Eight articles [7,10,27,31,33,34,37,39] reported the inci-
dences of IVH (grade of at least III) and involved nine
ventilation modes. However, we were able to include
only seven RCTs across seven ventilation modes in our
network meta-analysis because the incidence of IVH
(grade of at least III) in the article by Nafday et al. [37]
could not be incorporated in the network analysis. The
combined results of the direct and indirect comparisons
demonstrated that these seven ventilation modes exhib-
ited no differences in regard to the incidences of IVH
(grade of at least III) (Additional file 10). No statistical
inconsistencies were identified between the direct and
indirect comparisons, and none of the comparisons ex-
hibited statistical heterogeneity (Additional file 11).
Other outcomes
Ten studies [10,11,29,31,32,34-36,39,41] reported the in-
cidences of pneumothorax, eight studies [10-12,28,29,36,
Figure 4 Hazard ratios for death in the Bayesian network meta-
analysis versus high-frequency jet ventilation (HFJV). Hazard
ratios are estimated from a fixed-effects Bayesian network meta-
analysis. *95% confidence interval (CI) for the Bayesian network
meta-analysis does not contain 1. A/C, assist-control ventilation; A/C +
VG, assist-control plus volume-guarantee ventilation; A/C + VG+ RM,
assist-control plus volume-guarantee ventilation with recruitment
maneuver; CMV, continuous mandatory ventilation; HFFIV, high-
frequency flow interrupted ventilation; HFOV, high-frequency
oscillatory ventilation; IMV, intermittent mandatory ventilation; PSV,
pressure support ventilation; PSV + VG, pressure support ventilation
with volume-guarantee ventilation; PTV, patient-triggered ventilation;
SIMV, synchronized intermittent mechanical ventilation; SIMV + PSV,
synchronized intermittent mechanical ventilation with pressure support
ventilation; SIMV + VG, synchronized intermittent mechanical
ventilation with volume-guarantee ventilation; SIPPV + VG, synchronized
intermittent positive pressure ventilation plus volume-guarantee
ventilation; V-C, volume-controlled (through adjusting the delivered
tidal volume).
Figure 3 Hazard ratios for death in the Bayesian network meta-
analysis versus SIMV + PSV. Hazard ratios are estimated from a
fixed-effects Bayesian network meta-analysis. *95% confidence
interval (CI) for the Bayesian network meta-analysis does not contain
1. A/C, assist-control ventilation; A/C + VG, assist-control plus volume-
guarantee ventilation; A/C + VG + RM, assist-control plus volume-
guarantee ventilation with recruitment maneuver; CMV, continuous
mandatory ventilation; HFFIV, high-frequency flow interrupted
ventilation; HFJV, high-frequency jet ventilation; HFOV, high-frequency
oscillatory ventilation; IMV, intermittent mandatory ventilation; PSV,
pressure support ventilation; PSV + VG, pressure support ventilation
with volume-guarantee ventilation; PTV, patient-triggered ventilation;
SIMV, synchronized intermittent mechanical ventilation; SIMV + PSV,
synchronized intermittent mechanical ventilation with pressure support
ventilation; SIMV + VG, synchronized intermittent mechanical
ventilation with volume-guarantee ventilation; SIPPV + VG, synchronized
intermittent positive pressure ventilation plus volume-guarantee
ventilation; V-C, volume-controlled (through adjusting the delivered
tidal volume).
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[6,10,12,27,32,33,38,41] reported the length of hospital
stay, and two studies [27,38] reported the ICU length of
stay. Unfortunately, certain treatment measures were
isolated from the remaining treatment measures in these
studies; therefore, the aforementioned outcomes could
not be examined via network meta-analysis.Discussion
The diversity and strength of a network are determined
by the number of different interventions and compari-
sons of interventions that are available, how represented
they are in the network, and how much evidence they
carry. A severe imbalance in regard to the amount of
evidence for each intervention may affect the power and
reliability of the overall analysis. Random-effects meta-
analysis models can accommodate unexplained hetero-
geneity for the available pairwise comparisons and often
make the incoherence signals less prominent. None of
the comparisons identified statistical heterogeneity in our
network meta-analysis; thus, we chose a Bayesian fixed-
effects model based on the guidelines of Dias et al. [21].
Because of the limitations of a traditional meta-analysis,
Bhuta and Henderson-Smart [8] could only performpairwise comparisons of the HFJV and CV modes; how-
ever, various modes of ventilation are used for the MV of
infants with RDS, such as the intermittent mandatory ven-
tilation (IMV), PTV, and HFJV modes. By taking advan-
tage of a network meta-analysis, we compared all MV
modes from acceptable RCTs for infants with RDS to date.
To the best of our knowledge, the current investigation is
the first application of a network meta-analysis to the MV
modes of infants with RDS, and the results obtained from
the current analyses provide suggestions for the treatment
of infants with RDS.
The network meta-analysis results demonstrated that the
TCPL, HFOV, SIMV+VG, and V-C modes were associated
with a lower mortality rate in infants with RDS compared
with the SIMV+ PSV mode. Moreover, the V-C mode was
associated with a lower mortality rate in infants with RDS
than the HFJV and PTV modes. No differences were iden-
tified in regard to the TCPL, HFOV, SIMV, PSV + VG, or
V-C modes with respect to the incidences of PDA.
We demonstrated that the SIMV + VG ventilation
mode was the most successful at decreasing the mortal-
ity of infants with RDS but that the V-C mode ranked
second. In addition, the A/C ventilation mode was asso-
ciated with the worst in that it had the highest potential
Figure 5 Hazard ratios for death in the Bayesian network meta-
analysis versus patient-triggered ventilation (PTV). Hazard ratios
are estimated from a fixed-effects Bayesian network meta-analysis.
*95% confidence interval (CI) for Bayesian network meta-analysis
does not contain 1. A/C, assist-control ventilation; A/C + VG, assist-
control plus volume-guarantee ventilation; A/C + VG + RM, assist-
control plus volume-guarantee ventilation with recruitment maneuver;
CMV, continuous mandatory ventilation; HFFIV, high-frequency flow
interrupted ventilation; HFJV, high-frequency jet ventilation; HFOV,
high-frequency oscillatory ventilation; IMV, intermittent mandatory
ventilation; PSV, pressure support ventilation; PSV + VG, pressure
support ventilation with volume-guarantee ventilation; SIMV,
synchronized intermittent mechanical ventilation; SIMV + PSV,
synchronized intermittent mechanical ventilation with pressure support
ventilation; SIMV + VG, synchronized intermittent mechanical
ventilation with volume-guarantee ventilation; SIPPV + VG, synchronized
intermittent positive pressure ventilation plus volume-guarantee
ventilation; V-C, volume-controlled (through adjusting the delivered
tidal volume).
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SIMV+ PSV mode ranked second to last. But the prob-
ability ranking represents only a possibility without cer-
tainty; combining the direct and indirect evidence analysis
on overall mortality has more reference significance.
VG and V-C ventilation are modes of volume-targeted
ventilation that can ensure a constant target volume de-
livery via automatic adjustment of the peak inspiratory
pressure from breath to breath on the basis of changes
in pulmonary compliance (such as auto-weaning) [42,43].
Studies [12,44] have demonstrated that the VG ventilation
mode has certain advantages, such as the prevention of
lung atelectasis as well as the reduction of ventilation dur-
ation and the incidence of BPD and IVH, in infants with
RDS; these advantages may occur through the previously
discussed mechanism that can ensure the delivery of a
constant tidal volume close to a physiological level via the
adjustment of the peak inspiratory pressure (PIP) [42].
SIMV may reduce the duration of MV and oxygen de-
pendency because it may also minimize oxygen therapy to
prevent the development of severe BPD and retinopathy
of prematurity (ROP) [23,45].
V-C may benefit from better lung recruitment and
ventilation perfusion matching [11]. Furthermore, thelimitation of excessive tidal volume and the automatic
reduction of PIP may improve venous return and car-
diac output, which further improves cerebral blood
flow [46].
Lista et al. [36] demonstrated that pro-inflammatory
cytokines are substantially increased and MV lasted
longer in infants with RDS during the PSV ventilation
mode. Moreover, pulmonary inflammation and oxygen
toxicity are likely important predisposing factors in
the development of chronic lung disease [36]. Be-
cause relatively few participants received the A/C
ventilation mode, these results are more likely to be
biased [47].
Limitations
Our research has certain limitations. First, few experi-
ments examined (and therefore few participants re-
ceived) the A/C and A/C + VG + recruitment maneuver
(RM) ventilation modes compared with the other modes.
In addition, there was a lack of relevant treatment mea-
sures; thus, the meta-analysis results might be prone to
bias. Future multicenter comparisons that involve large
sample sizes and directly perform parallel comparisons
of ventilation modes are needed to confirm our results.
Second, because the results of the included experiments
are incomplete, the network meta-analysis of the inci-
dences of pneumothorax and BPD as well as the lengths
of ICU and hospital stay was not conducted. Therefore,
the results of the current investigation are relatively sim-
ple, and comprehensive and diverse conclusions cannot
be provided. Third, the ventilation mode during the
period of weaning may have an effect on the treatment
of infants with RDS; however, given that the time for
weaning is so short, we did not consider the ventilation
mode during the period of weaning in our network
meta-analysis. Finally, surfactant is an important drug
for preterm infants with RDS. However, nearly every in-
fant has used surfactant in our included literatures; thus,
we also did not consider the use of surfactant in our
analyses.
Conclusions
Compared with the SIMV + PSV ventilation mode, the
TCPL, HFOV, SIMV + VG, and V-C ventilation modes
are associated with lower mortality.
Key messages
 MV remains an essential and life-saving technique
to care for preterm infants with RDS for whom non-
invasive ventilation fails.
 We attempted to provide suggestions for the
treatment of infants with RDS by taking advantage
of a network meta-analysis.
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the TCPL, HFOV, SIMV + VG, and V-C ventilation
modes are associated with lower mortality.
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